BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

621 related articles for article (PubMed ID: 16293236)

  • 1. Bioscavengers for the protection of humans against organophosphate toxicity.
    Doctor BP; Saxena A
    Chem Biol Interact; 2005 Dec; 157-158():167-71. PubMed ID: 16293236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suitability of human butyrylcholinesterase as therapeutic marker and pseudo catalytic scavenger in organophosphate poisoning: a kinetic analysis.
    Aurbek N; Thiermann H; Eyer F; Eyer P; Worek F
    Toxicology; 2009 May; 259(3):133-9. PubMed ID: 19428953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In search of a catalytic bioscavenger for the prophylaxis of nerve agent toxicity.
    diTargiani RC; Chandrasekaran L; Belinskaya T; Saxena A
    Chem Biol Interact; 2010 Sep; 187(1-3):349-54. PubMed ID: 20176006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral administration of pyridostigmine bromide and huperzine A protects human whole blood cholinesterases from ex vivo exposure to soman.
    Gordon RK; Haigh JR; Garcia GE; Feaster SR; Riel MA; Lenz DE; Aisen PS; Doctor BP
    Chem Biol Interact; 2005 Dec; 157-158():239-46. PubMed ID: 16256090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human serum butyrylcholinesterase: in vitro and in vivo stability, pharmacokinetics, and safety in mice.
    Saxena A; Sun W; Luo C; Doctor BP
    Chem Biol Interact; 2005 Dec; 157-158():199-203. PubMed ID: 16263104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aging-resistant organophosphate bioscavenger based on polyethylene glycol-conjugated F338A human acetylcholinesterase.
    Mazor O; Cohen O; Kronman C; Raveh L; Stein D; Ordentlich A; Shafferman A
    Mol Pharmacol; 2008 Sep; 74(3):755-63. PubMed ID: 18523134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of inhibition, reactivation and aging kinetics of highly toxic organophosphorus compounds with human and pig acetylcholinesterase.
    Aurbek N; Thiermann H; Szinicz L; Eyer P; Worek F
    Toxicology; 2006 Jul; 224(1-2):91-9. PubMed ID: 16720069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A collaborative endeavor to design cholinesterase-based catalytic scavengers against toxic organophosphorus esters.
    Masson P; Nachon F; Broomfield CA; Lenz DE; Verdier L; Schopfer LM; Lockridge O
    Chem Biol Interact; 2008 Sep; 175(1-3):273-80. PubMed ID: 18508040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylaxis against soman inhalation toxicity in guinea pigs by pretreatment alone with human serum butyrylcholinesterase.
    Allon N; Raveh L; Gilat E; Cohen E; Grunwald J; Ashani Y
    Toxicol Sci; 1998 Jun; 43(2):121-8. PubMed ID: 9710953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzyme-kinetic investigation of different sarin analogues reacting with human acetylcholinesterase and butyrylcholinesterase.
    Bartling A; Worek F; Szinicz L; Thiermann H
    Toxicology; 2007 Apr; 233(1-3):166-72. PubMed ID: 16904809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholinesterases as scavengers for organophosphorus compounds: protection of primate performance against soman toxicity.
    Doctor BP; Blick DW; Caranto G; Castro CA; Gentry MK; Larrison R; Maxwell DM; Murphy MR; Schutz M; Waibel K
    Chem Biol Interact; 1993 Jun; 87(1-3):285-93. PubMed ID: 8343986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioscavenger for protection from toxicity of organophosphorus compounds.
    Saxena A; Sun W; Luo C; Myers TM; Koplovitz I; Lenz DE; Doctor BP
    J Mol Neurosci; 2006; 30(1-2):145-8. PubMed ID: 17192662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance to organophosphorus agent toxicity in transgenic mice expressing the G117H mutant of human butyrylcholinesterase.
    Wang Y; Boeck AT; Duysen EG; Van Keuren M; Saunders TL; Lockridge O
    Toxicol Appl Pharmacol; 2004 May; 196(3):356-66. PubMed ID: 15094306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of human and guinea pig acetylcholinesterase sequences and rates of oxime-assisted reactivation.
    Cadieux CL; Broomfield CA; Kirkpatrick MG; Kazanski ME; Lenz DE; Cerasoli DM
    Chem Biol Interact; 2010 Sep; 187(1-3):229-33. PubMed ID: 20433814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress in the development of enzyme-based nerve agent bioscavengers.
    Nachon F; Brazzolotto X; Trovaslet M; Masson P
    Chem Biol Interact; 2013 Dec; 206(3):536-44. PubMed ID: 23811386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical treatment of acute poisoning with organophosphorus and carbamate pesticides.
    Jokanović M
    Toxicol Lett; 2009 Oct; 190(2):107-15. PubMed ID: 19651196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonquaternary reactivators for organophosphate-inhibited cholinesterases.
    Kalisiak J; Ralph EC; Cashman JR
    J Med Chem; 2012 Jan; 55(1):465-74. PubMed ID: 22206546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetylcholinesterase inhibition: does it explain the toxicity of organophosphorus compounds?
    Maxwell DM; Brecht KM; Koplovitz I; Sweeney RE
    Arch Toxicol; 2006 Nov; 80(11):756-60. PubMed ID: 16770629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment with pyridinium oximes improves antidotal therapy against tabun poisoning.
    Lucić Vrdoljak A; Calić M; Radić B; Berend S; Jun D; Kuca K; Kovarik Z
    Toxicology; 2006 Nov; 228(1):41-50. PubMed ID: 16982122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amidine-oximes: reactivators for organophosphate exposure.
    Kalisiak J; Ralph EC; Zhang J; Cashman JR
    J Med Chem; 2011 May; 54(9):3319-30. PubMed ID: 21438612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.